Client
SAD Clinical Trials
Industry
Health & Medicine
Role
Lead designer
Date
Nov 29, 2024

Clinical Trial Recruitment Optimization: A Conversion-Driven UX Strategy

Clinical trial recruitment faces unique conversion challenges: vulnerable populations, trust barriers, and complex screening requirements. This case study demonstrates how strategic UX thinking—grounded in behavioral psychology research and data-driven hypothesis testing—transformed a Seasonal Affective Disorder clinical trial website. The result: 29% reduction in form abandonment, 1.8x increase in qualified patient leads, and accelerated study timelines across 10K+ monthly active users.

Introduction

A UX Challenge Rooted in Skepticism

Clinical trial recruitment operates under extraordinary constraints: Users arrive with inherent skepticism about medical research and regulatory requirements demand extensive screening—a single friction point can eliminate weeks of recruitment progress.

When a pharmaceutical research firm approached me to design their Seasonal Affective Disorder (SAD) clinical trial website, they faced a critical conversion problem—their existing screening funnel was hemorrhaging 34% of potential participants.

The client projected 8,000-11,000 monthly active users driven by advertising and physician referrals, but their previous campaign data revealed a troubling pattern: 34% of users who began the pre-screening questionnaire abandoned it before completion.

With study timelines directly tied to enrollment velocity and recruitment costs averaging $800-$1,200 per qualified participant, this abandonment rate represented both delayed research outcomes and could account for as much as $180,000 in monthly budget waste. Every percentage point improvement in completion rates would accelerate the path from research to treatment availability.

Challenge: User Psychology vs. Operational Protection

My initial analysis identified a critical mismatch between user psychology and information flow, but the client's resistance to early location disclosure wasn't arbitrary—it was rooted in legitimate operational concerns. Their previous campaign had experienced a significant problem: Unqualified individuals calling clinical trial sites directly, overwhelming research coordinators with inquiries from people who hadn't been medically screened, lived hundreds of miles outside catchment areas, or didn't meet basic demographic or diagnostic eligibility criteria.

The existing funnel followed a "qualify first, inform later" model specifically to protect clinical sites from this operational burden. Only after users completed pre-screening and demonstrated basic medical eligibility would they receive specific facility contact information. This approach made operational sense from a workflow perspective but violated fundamental principles of commitment psychology: Users need to confirm logistical feasibility before investing cognitive effort in multi-step processes.

This reluctance from trial site providers wasn't trivial—many had nearly withdrawn from future studies due to coordinator burnout from unqualified inquiries. The volume overwhelmed small research teams and created negative experiences for both coordinators and callers, who often learned mid-conversation they were ineligible.

Hypothesis: Two-Tiered Transparency as Strategic Compromise

My hypothesis: A significant portion of abandonment stemmed from geographic uncertainty—those users were either (1) assuming no locations existed near them and abandoning preemptively, or (2) were unwilling to "gamble" on the possibility of there being a viable test site. Any solution would need to balance user conversion psychology with operational realities and provider relations.

The strategic challenge wasn't just moving information earlier—it was designing a two-tiered transparency system that gave users the geographic confidence they needed to commit to screening while protecting clinical sites from premature contact. The key was distinguishing geographic proximity data (what users needed for decision-making: "Is there a location near me?") from facility contact details (what caused operational problems: specific addresses, phone numbers, coordinator names).

Compromise: Navigating Operational Constraints

The client's initial resistance to early location disclosure stemmed from reluctance from providers when approached to be a test site due to repeated called from individuals who hadn't been medically screened, lived hundreds of miles outside catchment areas, or who didn't meet basic demographic or diagnostic eligibility criteria. This volume overwhelmed small research teams and created negative experiences for both coordinators and callers (who often learned mid-conversation they were ineligible).

The post-screening location reveal served as a crude filter: While having only medically pre-qualified users receive facility contact information dramatically reduced unqualified inquiries, this operational protection came at a severe conversion cost—34% abandonment from users who changed their minds about completing the screening.

Research Methods & Data

  1. Baseline Data Analysis: Reviewed analytics from the client's recent clinical trial campaigns to establish conversion benchmarks and identify drop-off patterns.
  2. Behavioral Psychology Research: Studied principles of form design and progressive disclosure to understand how information sequencing affects completion rates.
  3. Friction Mapping: Identified potential abandonment points throughout the screening flow where uncertainty or cognitive load might cause users to quit

My Solution

Balancing Transparency With Operational Protection

The breakthrough came from reframing the problem: Users didn't need specific facility addresses and phone numbers to make participation decisions—they needed to confirm that trial locations existed within reasonable proximity. This insight enabled a strategic compromise that satisfied both user psychology and operational constraints.

I proposed a two-tiered location disclosure system.

(1) Pre-Screening City Directory: A publicly accessible "Study Locations" page listing trial cities containing participating test centers but without specific facility details. This gave geographically-conscious users the confirmation they needed ("Yes, there's a location within 30 minutes of me") without exposing clinical coordinators to unqualified inquiries.

(2) Post-Qualification Facility Details: Only after users completed medical pre-screening and demonstrated basic eligibility would they receive specific facility names, addresses, contact information, and coordinator details—maintaining the operational protection the client required while eliminating the premature abandonment caused by geographic uncertainty.

Supporting this core architectural change, I implemented strategic CTA placement throughout the site with microcopy emphasizing location availability ("Study locations available in [X] cities across [regions]"), progressive disclosure within the screener itself to reduce cognitive load, and comprehensive analytics tracking to monitor how users navigated between the city directory and screening entry points.

Results: Strategic Compromise Delivers Dual Wins

Within three weeks of launch, form abandonment dropped to 23%–a 29% reduction compared to the baseline 34% rate. The two-tiered approach delivered on both objectives: Users gained the geographic transparency they needed to commit to screening while clinical sites experienced zero increase in unqualified contact attempts—in fact, coordinator feedback indicated that qualified leads arriving from the new funnel seemed "better-informed and more committed" than previous campaigns.

Translating this to business outcomes: The site generated nearly 2,000 additional completed screenings per month, resulting in 1.8x more qualified leads entering the clinical trial pipeline. Per-participant recruitment costs dropped by approximately $290, study enrollment timelines accelerated by 2-3 weeks, and patient experience improved measurably—users appreciated not being "surprised" by location options (post-enrollment survey data, n=16).

How Strategic IA Reduced Form Abandonment by 29% and Generated 1.8x More Qualified Enrollees

Discovery

Identifying Friction Points

To ground design decisions in evidence rather than assumptions, I conducted a three-stream research process combining quantitative baseline data, behavioral psychology literature, and friction mapping analysis. The goal was to pinpoint exactly where and why 34% of users were abandoning the screening funnel.

UX Strategy & Design Research

Logistical Uncertainty

Analytics showed users spent an average of 8.3 seconds hovering over the "Start Screening" CTA before either clicking or bouncing—abnormally long hesitation suggesting decision paralysis.

Exit surveys confirmed this: 68% of survey respondents cited "didn't know if locations were near me" as abandonment reason. The silent question—"Is there even a location accessible to me?"—prevented screening initiation for thousands of potential participants every month.

Trust & Credibility Deficits

Heatmap analysis from prior campaigns showed users spent more than 2x longer on the "About This Study" and "Privacy Policy" pages—suggesting that trust verification was a critical pre-commitment behavior. The design implication, then, is that transparency and credibility signaling needed to be architectural, not just cosmetic.

It was noted, too, that clinical trials carry historical stigma from unethical research practices.

Time Investment Anxiety

Users hesitated to commit several minutes to the screener when uncertain they'd qualify based on location. This created a destructive loop—abandonment without screening meant the site never gathered enough qualified leads, while aggressive advertising to compensate only brought more skeptical users likely to abandon.

Breaking this loop required reducing perceived risk of "wasted time."

Wireframes & Prototyping

Notes

In the synthesis of data and research, users experiencing logistical uncertainty were confirmed to be more likely to distrust the study, more sensitive to cognitive load, and more anxious about time investment.

The two-tiered location solution needed to address all three challenges simultaneously: providing geographic confidence (addressing uncertainty), demonstrating transparency (building trust), and confirming feasibility upfront (eliminating time investment risk).

This research foundation transformed a generic "improve the form" brief into a strategic "redesign the information architecture to respect user psychology while protecting operational workflows" challenge—setting the stage for a solution that would ultimately deliver 29% abandonment reduction and 1.8x lead generation improvement.

Wireframes

SAD Trials Website
SAD Trials Website
SAD Trials Website
SAD Trials Website
SAD Trials Website
SAD Trials Website
SAD Trials Website
SAD Trials Website
Lead designer

Results & Impact

Within three weeks of launch, the two-tiered location strategy delivered measurable impact across both user conversion and operational protection.

Form abandonment dropped from 34% to 23%—a 29% reduction—while screener completion rates improved 18%. This translated to 1.8x increase in qualified leads (from ~65/month to ~115/month), generating approximately 2,000 additional completed screenings monthly across 10,000+ MAU. The business impact: estimated $290 reduction in per-participant recruitment costs and 4-6 week acceleration in projected study enrollment timeline, directly impacting time-to-market for treatment research.

Lessons & Next Steps

What Worked Well

  • User-driven insights shaped a better experience.
  • Simplified interactions led to higher conversions.

Future Improvements

  • Add video testimonials to further humanize the trial.
  • Implement real-time chat support for participant questions.

Final Thoughts

This project reinforced how UX in healthcare isn’t just about usability—it’s about empathy. By anticipating real-world friction points, I was able to create a more inclusive, accessible, and effective digital experience.‍

Timeline

Project Schedule

I worked in close partnership with the client through each phase of the project, from initial discovery to final approval.

Line illustration showing a website being designed

Research & Discovery

September 30, 2024

Conducted discovery sessions with the client to define goals, target audience, and market positioning. Analyzed competitors, industry trends, and key insights to inform strategic direction.

Prototyping

October 3, 2024

Developed mood boards, high-fidelity wireframes, and interactive prototypes in Figma to visualize design concepts. Collaborated with the client to refine and finalize their preferred concept.

Design

October 17, 2024

Built the sitemap, configured the tech stack, and implemented SEO-optimized copy for landing pages. Developed custom scripts, integrated plugins, and optimized site functionality for seamless performance.

Finalization

November 24, 2024

Led final client review to ensure all project elements aligned with expectations and objectives. Secured approval, marking the project's official point of completion.